Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)
Página oficial de la convocatoria ↗
In brief, in English
This funding opportunity supports exploratory and early-stage research projects focused on modulating undruggable target classes relevant to intractable human diseases. The provided text does not specify eligible applicant types.
Written by a model from the publisher's text. The official page is the authority. How data is produced
The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications for exploratory and early-stage projects that focus on undruggable target classes within intractable human disease. Applicants will identify a human disease relevant undruggable target class and develop a method or agent that is selective for one or more targets within that target class. This NOFO is intended to jumpstart research that demonstrates innovative strategies to modulate targets that cannot be addressed by established therapeutic types, furthering the development of methods and/or agents selective for undruggable target classes.
Historial de cambios
First seen 28 Sept 2026, last checked 22 Nov 2026. 20 recorded versions.
- 22 Oct 2026 · 7ff23cb88758
- 22 Oct 2026 · b91bbfd1cfcc
- 21 Oct 2026 · 8f0d319c6fc9
- 20 Oct 2026 · 4a9011444c55
- 19 Oct 2026 · 2c42b0c0e7b4
- 18 Oct 2026 · 0487021acfd4
- 17 Oct 2026 · 894b3d9a9e5b
- 16 Oct 2026 · 397e976ced6d
- 15 Oct 2026 · 537e89e4fc3e
- 14 Oct 2026 · e7b99ce55686
- 13 Oct 2026 · 9d2fa36c641f
- 12 Oct 2026 · f25145c51e9b
- 11 Oct 2026 · 4a9011444c55
- 10 Oct 2026 · b162a55c16fc
- 09 Oct 2026 · 355c233782f8
- 08 Oct 2026 · 2fcee73cfb18
- 07 Oct 2026 · 322c2168b48b
- 06 Oct 2026 · a2e1c7c75b97
- 05 Oct 2026 · d4f540465119
- 04 Oct 2026 · 578723b97fc5